MD, Medical Oncology Fellow at @AnkaraUni

Ankara, Türkiye
📢Our multicenter study of HER2-low vs HER2-null advanced gastric cancer is now in @JAMANetworkOpen • 522 patients • HER2-low:↑liver mets,↑CEA, worse ECOG; not independently prognostic Thanks @EduardoTB94 &collaborators @OncoAlert @yekeduz_emre @DrYukselUrun @Ankaratip1945
1
5
20
2,270
Beliz Bahar Karaoğlan retweeted
Funding opportunities for lobular breast cancer research @AACR @LobularBCA !
The AACR-Lobular Breast Cancer Alliance Invasive Lobular Carcinoma Research Challenge Grants provide $50,000 over one year to stimulate creative, paradigm-shifting ideas in invasive lobular carcinoma. Apply by September 10. Learn more: brnw.ch/21x5zjJ #AACRGrants
2
4
799
Our new study has been published in Surgical Practice. Among 512 general surgeons in Türkiye, video game experience was associated with a greater preference for laparoscopic and robotic surgery. Although this does not prove better surgical performance, it raises interesting questions for modern surgical education. Congratulations to our entire team! doi.org/10.1111/1744-1633.70… @s_utkucelik
2
4
22
1,050
Congratulations @yekeduz_emre ! 👏 So well deserved. Having mentors and role models like you to look up to is truly inspiring and motivates us to aim higher. So proud of you and this wonderful achievement! 🎉
🎉🎉🎉Honoured and deeply grateful to share that I have been selected as a 2026 recipient of the @myESMO "ESMO Leadership and Career Development Award LDCA", alongside an exceptional group of highly valued and inspiring researchers from around the world. This recognition is a tremendous privilege and a meaningful milestone in my academic and professional journey. I sincerely thank @myESMO for this prestigious opportunity and for supporting the next generation of leaders in oncology. Very special thanks to my great mentors @DrChoueiri @DrYukselUrun and Prof. Hakan Akbulut for their lifelong support! @TeresaSAmaral @ravikanesvaran @OncoAlert @AnkaraUni @AUTF_DEKANLIK
1
1
13
660
Great to be in Bern for the International Chronobiology and Chronomedicine Workshop and to have the chance to present our work on chronoimmunotherapy. Many thanks to Dr. Berna Özdemir for the invitation and to @yekeduz_emre for his support throughout the study.
1
3
25
858
🌿 Happy to share that I’m now an Associate Professor Grateful to my mentors at Ankara University and to @mertkaraoglan for his endless patience and support The journey is still long. Looking forward to learning, growing, and building meaningful things together 💫
5
3
70
6,345
Beliz Bahar Karaoğlan retweeted
💥Exciting news! @JAMANetworkOpen Proud to contribute to expanding the evidence on HER2-low #gastriccancer, providing insights into its clinical and therapeutic implications. Looking forward to more collaborations ahead! 🚀 @VHIO @GrupoTTD
📢Our multicenter study of HER2-low vs HER2-null advanced gastric cancer is now in @JAMANetworkOpen • 522 patients • HER2-low:↑liver mets,↑CEA, worse ECOG; not independently prognostic Thanks @EduardoTB94 &collaborators @OncoAlert @yekeduz_emre @DrYukselUrun @Ankaratip1945
1
8
654
A pleasure working together, @EduardoTB94 ! Excited for what's coming next, and hopefully many more projects together 🤝
Proud to present our multicenter study on the clinical and molecular landscape of HER2-low GEA at #ESMOGI2026 @VHIO Great collaborating with my Turkish friend @BbaharK on this exciting project 🇹🇷🇪🇸 Our NGS-based molecular clustering publication soon! 🤞🏻
8
967
Beliz Bahar Karaoğlan retweeted
Rest in peace, Champ ❤️ @LFC
Rest in peace, Kevin Keegan ❤️
3
13
5,651
Proud to share the first publication of the Ankara University Colorectal ERAS Study Group, now online in BMC Surgery. This is more than a paper — it is the first fruit of years of patience, dedication, and true teamwork. My heartfelt thanks to every member of our surgical, anesthesia, and ERAS nursing teams for their loyalty and harmony throughout this journey. Every line of our prospective database carries your effort. In 151 patients undergoing elective right colectomy for colon cancer, higher ERAS compliance was associated with a significantly shorter hospital stay, and higher preoperative compliance was independently associated with lower odds of major complications. The message is clear: the benefit of ERAS lies not in having a protocol, but in delivering it consistently — and recovery begins before the incision. The first of many to come. Team work makes the dream work. 📄 doi.org/10.1186/s12893-026-0… rdcu.be/ftzje #ERAS #ColorectalSurgery #EnhancedRecovery @BMC_series @BMCSurgery @s_utkucelik @eras_turkiye @ErasSociety @TKRCD_
2
11
620
Beliz Bahar Karaoğlan retweeted
A Great Week of Learning and Collaboration at ESO CAS-GI and ESMO GI26 - Beliz Bahar Karaoğlan @BbaharK oncodaily.com/voices/beliz-b…
1
3
213
Beliz Bahar Karaoğlan retweeted
For patients undergoing upfront surgery for colorectal liver metastases, postsurgical 🧬 ctDNA identifies who will derive overall survival benefit from (m)adjuvant chemotherapy, and who can safely avoid it. 🧬MRD (+): Adjuvant chemotherapy significantly improved both disease-free survival and overall survival. 🧬 MRD (-): Patients experienced excellent long-term survival regardless of whether they received chemotherapy or just observation. @JAMAOnc @OncoAlert @OpenMedicineHQ @isliquidbiopsy
3
19
34
2,674
Beliz Bahar Karaoğlan retweeted
🟠Adjuvant chemotherapy regimens in resected biliary tract cancers TOG/GI-SAFRADJU-2501 @IntJCanc ➡️Our national registry study ➡️44 centers, 617 patients ❗️GemCis, GemCape or Gem are not superior to Cape ✅A positive signal for additional RT 🚨ECOG, T, N, R1 are prognostic 👉onlinelibrary.wiley.com/doi/… #cancer #oncology #MedX #biliary #cholangiocarcinoma #chemotherapy #adjuvant #gastrointestinal @OncoAlert @LorenzaRimassa
3
33
70
13,738
Beliz Bahar Karaoğlan retweeted
0 Yazıyla Sıfır…. HPV aşısı yapılan genç kadınlarda rahim ağzı kanserine bağlı ölümler sıfıra indi… Mümkün…
Cervical cancer deaths fall to zero in young women given vaccine bbc.in/4ovjOLq
1
1
24
1,391
Beliz Bahar Karaoğlan retweeted
One of most interesting rectal ca studies at #ASCO26 P3 RCT in pMMR LARC: Node-sparing short-course RT + CAPOX + tislelizumab doubled pCR v conventional SCRT + CAPOX (61 v 29%) Hypothesis = sparing elective node RT preserves antitumor immunity & improves PD1 response @OncoAlert
7
53
117
7,395
Beliz Bahar Karaoğlan retweeted
First ASCO. Won’t be the last!!! 🙌 From witnessing history being made with #daraxonrasib ✨ to finding my people at @ASCOTECAG, this week reminded me exactly why I chose this path. An unforgettable mentorship session with @noha_soror, TikToking the halls with @Arosen380, connecting with @ibrahimsahinmd1 across the miles, and finding my true belonging in the IMG CoP community thanks to @nazlidizman @ZiadBakouny. Every moment felt meaningful. And what a way to close it all out with Drs. Yap, Simpkins & Postel-Vinay leaving the entire room inspired. 🔥 This is why we do what we do. Till next time #ASCO2026 #ASCO26 @ASCO 💙
3
12
1,333
Beliz Bahar Karaoğlan retweeted
Wonderful to reconnect with such a great collages at #ASCO2026. Looking forward to ongoing collaborations and new projects ahead. See you in Munich! 💫🙌🏻
My colleague and GI-oncology friend @EduardoTB94 stopped by my poster today, an honor and a pleasure!😊 Looking forward to returning the visit and meeting at his poster at ESMO GI next🤝 #ASCO2026 @ASCO @Erman_Akkus @OncoDailyGI
1
6
546
Yet another excellent poster from Dr. Bergerot @crisbergerot at #ASCO2026. Understanding how distress changes over time may help us identify vulnerable patients earlier and deliver more personalized #supportivecare @PallOncCoP @realbowtiedoc @ASCO
3
9
459
My colleague and GI-oncology friend @EduardoTB94 stopped by my poster today, an honor and a pleasure!😊 Looking forward to returning the visit and meeting at his poster at ESMO GI next🤝 #ASCO2026 @ASCO @Erman_Akkus @OncoDailyGI
1
6
809
Beliz Bahar Karaoğlan retweeted
🎉Our very own @BbaharK presenting our study at #ASCO26! I am extremely happy for being the senior author for the first time! In this real-world chrono-immunotherapy analysis, we used cluster analysis of ICI infusion timing up to 24 cycles for each patient and found that midday administration was associated with the longest overall survival in patients with metastatic cancer. 👉‼️Our translational study are on the way to better understand the biology behind these findings #Immunotherapy #CancerResearch @DrYukselUrun @AnkaraUni @AUTF_DEKANLIK @OncoReporte @OncoAlert @OpenMedicineHQ @mert_karaoglann @realbowtiedoc
10
24
1,517